Sirolimus

Sirolimus is a medicine used to prevent organ rejection after an organ transplant. It works by stopping the body's immune system from attacking the new organ. It's often given to people who have received a kidney, liver, or heart transplant. It's sometimes called Rapamune.

Brand names:Rapamune, Fyarro
Medication

What people taking Sirolimus report

Every report comes from a Lived member, sent anonymously.

Have you tried Sirolimus for Lymphangioleiomyomatosis?

NameHow it went

About Sirolimus

What It's For

Sirolimus, sold as Rapamune and as generic tablets and oral solution, is a prescription medicine that calms the immune system. Its main use is preventing rejection in people aged 13 and older who have received a kidney transplant. Rejection happens when the immune system treats the new kidney as foreign and attacks it, so people who receive a transplant take a combination of anti-rejection medicines. Sirolimus is usually started alongside cyclosporine (another anti-rejection medicine) and a corticosteroid. In people at lower risk of rejection, cyclosporine is often tapered off a few months after the transplant, and sirolimus continues. Sirolimus is also approved to treat lymphangioleiomyomatosis (LAM), a rare, slowly progressive lung disease that mainly affects women. In LAM, abnormal muscle-like cells grow in the lungs and lymphatic system, creating cysts that gradually reduce breathing capacity. Lung specialists recommend sirolimus for LAM, particularly when lung function is reduced or falling. Sirolimus is not recommended after a liver or lung transplant. Studies in those patients found serious complications, including deaths, graft loss and, in lung transplants, breakdown of the newly joined airways. Two other products contain sirolimus but are used very differently. Hyftor is a gel applied to the face to treat angiofibromas (small, raised facial growths) in people with tuberous sclerosis complex aged 6 and older. Fyarro is an intravenous form given by infusion to adults with a rare cancer called malignant PEComa. The rest of this page describes oral sirolimus.

How It Works

The immune system rejects a transplanted organ largely through T cells, white blood cells that multiply rapidly once they recognize tissue as foreign. Sirolimus blocks a protein inside cells called mTOR (mammalian target of rapamycin), which acts as a switch telling cells when to grow and divide. With mTOR blocked, T cells cannot multiply as readily in response to the signals that drive rejection, and the immune attack on the new kidney is held back. Because it works differently from cyclosporine and tacrolimus (another widely used anti-rejection medicine), sirolimus is started alongside cyclosporine, and cyclosporine can later be withdrawn in some people. Switching from cyclosporine or tacrolimus to sirolimus later on is a specialist decision: in a large trial it did not improve kidney function and caused more problems in people whose kidney function was already reduced. In LAM, the abnormal cells carry genetic changes that leave mTOR switched on, so they keep growing. By blocking mTOR, sirolimus slows the growth of these cells, which is how it helps stabilize lung function. It does not remove the cysts that have already formed.

Dosage & Administration

Oral sirolimus is taken once a day, as a tablet or a liquid. Take each dose the same way every day, either always with food or always without, because food changes how much medicine reaches the bloodstream. Swallow tablets whole; do not crush, chew or split them. People who cannot swallow tablets can be prescribed the oral solution. Someone also taking cyclosporine usually takes sirolimus about 4 hours after the cyclosporine dose, because taking them together raises sirolimus levels. The right dose differs a great deal between people, so the care team measures the trough level: the amount of sirolimus in the blood just before the next dose is due, when it is at its lowest. The dose is adjusted to keep this level within a target range set for the person's situation. For LAM, the usual target is 5 to 15 ng/mL (nanograms per milliliter), and transplant targets depend on the rest of the regimen. Because sirolimus stays in the body a long time, the team usually waits a week or two after a dose change before rechecking, and checks continue at least every few months once the dose is stable. Results from different lab methods are not interchangeable, so changing labs can matter. Do not change the dose or stop sirolimus, or any other anti-rejection medicine, without talking to the transplant team. If too much has been taken, call the care team or a pharmacist right away.

Side Effects

In people with LAM, the most common side effects are mouth sores, diarrhea, nausea, stomach pain, acne, headache, dizziness, colds and swelling of the legs and ankles. Most are mild and tend to appear in the first months of treatment. In people with a kidney transplant, common problems also include high blood pressure, urinary tract infections, joint and stomach pain, low red blood cell or platelet counts, and higher blood sugar. Raised cholesterol and triglycerides (fats in the blood) are very common with sirolimus, and many people need diet changes or a cholesterol-lowering medicine. Sirolimus also slows wound healing, which matters after transplant surgery and before any planned operation. Tell the care team about a wound that is red, draining or not closing. Fluid can collect in the legs or, less often, around the lungs or heart. The most serious risks come from suppressing the immune system. Sirolimus carries an FDA boxed warning, the agency's most prominent, that it increases the risk of serious infections and of lymphoma and other cancers. Skin cancer risk is also raised. Fever or chills should be reported to the care team right away. A new or worsening cough or shortness of breath also needs prompt attention, because sirolimus can rarely cause lung inflammation (pneumonitis) that improves when the dose is lowered or the drug is stopped. Sirolimus can rarely cause a serious allergic reaction or angioedema, a rapid swelling under the skin. Swelling of the face, lips, tongue or throat, or trouble breathing, needs emergency care right away.

Interactions & Warnings

Sirolimus is broken down by a liver enzyme (CYP3A4) that many other medicines speed up or slow down, so small changes elsewhere can push sirolimus levels too high or too low. Strong blockers of this enzyme should be avoided, including the antifungals ketoconazole, itraconazole and voriconazole and the antibiotics clarithromycin and erythromycin. So should strong speed-ups such as rifampin and rifabutin, antibiotics used for tuberculosis. Many other medicines, including some blood pressure and heart drugs (diltiazem, verapamil), seizure medicines, HIV and hepatitis C treatments, cannabidiol (CBD, including Epidiolex) and the herbal supplement St. John's wort, may require extra blood level checks or a dose change. Do not drink grapefruit juice or use it to mix the oral solution. Tell the care team and pharmacist about every new prescription, over-the-counter medicine and supplement. Taking sirolimus with an ACE inhibitor (a common type of blood pressure medicine) raises the chance of angioedema. Over the long term, sirolimus combined with cyclosporine can reduce kidney function, which is one reason cyclosporine is often withdrawn and kidney tests are checked regularly. Live vaccines, such as the measles, mumps and rubella (MMR) vaccine, the chickenpox vaccine and the yellow fever vaccine, should be avoided during treatment. Other vaccines may work less well, so timing is worth planning with the care team. Limit sun exposure and use protective clothing and a high-protection broad-spectrum sunscreen because of the higher skin cancer risk. Sirolimus can harm a developing baby. Women who could become pregnant should use highly effective birth control, starting before treatment, during treatment and for 12 weeks after the last dose, and should tell the care team right away about a possible pregnancy. It is not known whether sirolimus passes into breast milk, so feeding plans need discussion. Sirolimus can also lower sperm counts and may affect fertility in both men and women.

What to Expect

After a kidney transplant, sirolimus is one part of a lifelong anti-rejection plan. Early on, visits and blood tests are frequent, checking sirolimus levels, kidney function, blood counts, cholesterol and urine protein. As things stabilize, testing becomes less frequent, though a new medicine, illness or switch between tablet and liquid can prompt extra checks. The regimen may change over the years depending on kidney function, side effects and rejection risk. For LAM, sirolimus aims to stop or slow the loss of lung function rather than restore what has been lost. In the main clinical trial, lung function held steady over a year on sirolimus while it kept falling on placebo, and once sirolimus was stopped, the decline resumed at the same pace. For that reason, treatment is generally continued long term while it helps. Breathing tests every few months show whether it is working, and the medicine can also shrink kidney growths called angiomyolipomas and reduce fluid buildup from the lymphatic system in some people with LAM. People on sirolimus are more vulnerable to infections, so routine habits such as handwashing, keeping up with recommended non-live vaccines and reporting fevers early make a practical difference. Regular skin checks are worthwhile because of the higher skin cancer risk.

Questions to Ask Your Doctor

  1. 1.What trough level are we aiming for, and how often will my blood levels, kidney function and cholesterol be checked?
  2. 2.Will my cyclosporine or other anti-rejection medicines be reduced or stopped, and how will that change my sirolimus dose?
  3. 3.Which of my current medicines or supplements could change my sirolimus level, and who should I check with before starting something new?
  4. 4.How should we handle mouth sores, high cholesterol or slow wound healing if they happen, especially before any surgery?
  5. 5.What birth control or family-planning steps make sense while I take sirolimus and for the months after?

Last reviewed • Oct 2026

Educational content, not medical advice.